Kura Oncology Inc (KURA)
10.89
+0.09
(+0.83%)
USD |
NASDAQ |
Nov 25, 14:12
Kura Oncology Total Liabilities (Quarterly): 55.07M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 55.07M |
| June 30, 2024 | 49.05M |
| March 31, 2024 | 48.82M |
| December 31, 2023 | 51.66M |
| September 30, 2023 | 43.83M |
| June 30, 2023 | 35.06M |
| March 31, 2023 | 30.79M |
| December 31, 2022 | 36.03M |
| September 30, 2022 | 28.37M |
| June 30, 2022 | 21.93M |
| March 31, 2022 | 22.34M |
| December 31, 2021 | 27.44M |
| September 30, 2021 | 27.38M |
| June 30, 2021 | 26.34M |
| March 31, 2021 | 34.28M |
| December 31, 2020 | 36.31M |
| September 30, 2020 | 33.07M |
| June 30, 2020 | 30.63M |
| March 31, 2020 | 23.26M |
| Date | Value |
|---|---|
| December 31, 2019 | 23.19M |
| September 30, 2019 | 21.02M |
| June 30, 2019 | 19.10M |
| March 31, 2019 | 20.05M |
| December 31, 2018 | 21.39M |
| September 30, 2018 | 16.89M |
| June 30, 2018 | 17.23M |
| March 31, 2018 | 16.66M |
| December 31, 2017 | 15.99M |
| September 30, 2017 | 13.92M |
| June 30, 2017 | 12.21M |
| March 31, 2017 | 11.68M |
| December 31, 2016 | 12.94M |
| September 30, 2016 | 12.64M |
| June 30, 2016 | 11.70M |
| March 31, 2016 | 4.316M |
| December 31, 2015 | 5.156M |
| September 30, 2015 | 5.043M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
21.93M
Minimum
Jun 2022
55.07M
Maximum
Sep 2024
34.24M
Average
31.93M
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 1.665B |
| AIM ImmunoTech Inc | 10.68M |
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 478.84M |
| Shareholders Equity (Quarterly) | 423.77M |